PMC:7195088 / 16788-17038
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"913","span":{"begin":94,"end":99},"obj":"Disease"},{"id":"914","span":{"begin":101,"end":106},"obj":"Disease"},{"id":"915","span":{"begin":174,"end":179},"obj":"Disease"},{"id":"916","span":{"begin":181,"end":186},"obj":"Disease"}],"attributes":[{"id":"A913","pred":"tao:has_database_id","subj":"913","obj":"MESH:D005334"},{"id":"A914","pred":"tao:has_database_id","subj":"914","obj":"MESH:D003371"},{"id":"A915","pred":"tao:has_database_id","subj":"915","obj":"MESH:D005334"},{"id":"A916","pred":"tao:has_database_id","subj":"916","obj":"MESH:D003371"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"CT (NCT04255017, recruiting). Primary endpoints: (a) rate of disease remission (mild disease: fever, cough and other symptoms relieved with improved lung CT; severe disease: fever, cough and other symptoms relieved with improved lung CT, Spo 2 \u003e 93% "}
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T8","span":{"begin":149,"end":153},"obj":"Body_part"},{"id":"T9","span":{"begin":229,"end":233},"obj":"Body_part"}],"attributes":[{"id":"A8","pred":"fma_id","subj":"T8","obj":"http://purl.org/sig/ont/fma/fma7195"},{"id":"A9","pred":"fma_id","subj":"T9","obj":"http://purl.org/sig/ont/fma/fma7195"}],"text":"CT (NCT04255017, recruiting). Primary endpoints: (a) rate of disease remission (mild disease: fever, cough and other symptoms relieved with improved lung CT; severe disease: fever, cough and other symptoms relieved with improved lung CT, Spo 2 \u003e 93% "}
LitCovid-PD-UBERON
{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T5","span":{"begin":149,"end":153},"obj":"Body_part"},{"id":"T6","span":{"begin":229,"end":233},"obj":"Body_part"}],"attributes":[{"id":"A5","pred":"uberon_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"A6","pred":"uberon_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"CT (NCT04255017, recruiting). Primary endpoints: (a) rate of disease remission (mild disease: fever, cough and other symptoms relieved with improved lung CT; severe disease: fever, cough and other symptoms relieved with improved lung CT, Spo 2 \u003e 93% "}
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T17","span":{"begin":94,"end":99},"obj":"Phenotype"},{"id":"T18","span":{"begin":101,"end":106},"obj":"Phenotype"},{"id":"T19","span":{"begin":174,"end":179},"obj":"Phenotype"},{"id":"T20","span":{"begin":181,"end":186},"obj":"Phenotype"}],"attributes":[{"id":"A17","pred":"hp_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A18","pred":"hp_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/HP_0012735"},{"id":"A19","pred":"hp_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A20","pred":"hp_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/HP_0012735"}],"text":"CT (NCT04255017, recruiting). Primary endpoints: (a) rate of disease remission (mild disease: fever, cough and other symptoms relieved with improved lung CT; severe disease: fever, cough and other symptoms relieved with improved lung CT, Spo 2 \u003e 93% "}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T72","span":{"begin":50,"end":51},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T73","span":{"begin":149,"end":153},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T74","span":{"begin":149,"end":153},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T75","span":{"begin":229,"end":233},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T76","span":{"begin":229,"end":233},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T77","span":{"begin":242,"end":248},"obj":"http://purl.obolibrary.org/obo/CLO_0001230"},{"id":"T78","span":{"begin":242,"end":248},"obj":"http://purl.obolibrary.org/obo/CLO_0037237"},{"id":"T79","span":{"begin":242,"end":248},"obj":"http://purl.obolibrary.org/obo/CLO_0050903"},{"id":"T80","span":{"begin":242,"end":248},"obj":"http://purl.obolibrary.org/obo/CLO_0054249"},{"id":"T81","span":{"begin":242,"end":248},"obj":"http://purl.obolibrary.org/obo/CLO_0054250"},{"id":"T82","span":{"begin":242,"end":248},"obj":"http://purl.obolibrary.org/obo/CLO_0054251"},{"id":"T83","span":{"begin":242,"end":248},"obj":"http://purl.obolibrary.org/obo/CLO_0054252"}],"text":"CT (NCT04255017, recruiting). Primary endpoints: (a) rate of disease remission (mild disease: fever, cough and other symptoms relieved with improved lung CT; severe disease: fever, cough and other symptoms relieved with improved lung CT, Spo 2 \u003e 93% "}